| Patent application number | Description | Published |
|---|
| 20090270446 | DIAMINE DERIVATIVES - The present invention relates to diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for treating various diseases based on thromboembolism. | 10-29-2009 |
| 20090281074 | DRUG COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING THROMBOSIS OR EMBOLISM - Drug compositions containing a substituted diamine compound represented by formula (1): | 11-12-2009 |
| 20090312310 | Imidazothiazole derivatives - There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity: | 12-17-2009 |
| 20100093785 | DIAMINE DERIVATIVES - A compound represented by the general formula (1): | 04-15-2010 |
| 20100099660 | METHOD FOR TREATING THROMBOSIS OR EMBOLISM AND RELATED DISEASES - A method for treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing is provided. The method includes administration of an effective amount of a compound represented by formula (1): | 04-22-2010 |
| 20110077266 | Diamine Derivatives - The present invention relates to diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for treating various diseases based on thromboembolism. | 03-31-2011 |
